Comparative molecular field analysis-based predictive model of structure-function relationships of polyamine transport inhibitors in L1210 cells

Cancer Research

Volumn 57, Issue 2, 1997, Pages 234-239

  Li, Yanlong ^a   MacKerell Jr , Alexander D ^a   Egorin, Merrill J ^b,c   Ballesteros, Michael F ^b   Rosen, D Marc ^b   Wu, Yi Ying ^a   Blamble, Deborah A ^a   Callery, Patrick S ^a,b,d  

^a School of Pharmacy   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; POLYAMINE DERIVATIVE; SPERMIDINE DERIVATIVE;

ARTICLE; CELL MEMBRANE TRANSPORT; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; POLYAMINE METABOLISM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRANSPORT KINETICS;

ANIMALS; LEUKEMIA L1210; MICE; MODELS, CHEMICAL; POLYAMINES; SPERMIDINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031032026     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Heby, O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation, 19: 1-20, 1981
2. Tabor, C. W., and Tabor, H. Transport systems for 1,4-diaminobutane, spermidine, and spermine in Escherichia coli. J. Biol. Chem., 241: 3714-3723, 1966.
3. Seiler, N., and Dezeure, F. Polyamine transport in mammalian cells. Int. J. Biochem., 22: 211-218, 1990.
4. Grillo, M. A., and Colombatto, S. Polyamine transport in cells. Biochem. Soc. Trans., 22: 894-898, 1994.
5. Gordonsmith, R. H., Brooke-Taylor, S., Smith, L. L., and Cohen, G. M. Structural requirements of compounds that inhibit pulmonary diamine accumulation. Biochem. Pharmacol., 32: 3701-3709, 1983.
6. O'Sullivan, M. C., Golding, B. T., Smith, L. L., and Wyatt, I. Molecular features necessary for the uptake of diamines and related compounds by the polyamine receptor of rat lung slices. Biochem. Pharmacol., 41: 1839-1848, 1991.
7. Khan, N. A., Quemener, V., Seiler, N., and Moulinoux, J-P. Mechanism of spermidine uptake in cultured mammalian cells and its inhibition by some polyamine analogues. Pathobiology, 58: 172-178, 1990.
8. McCormack, S. A., and Johnson, L. R. Putrescine uptake and release by colon cancer cells. Am. J. Physiol., 256: G868-G877, 1989.
9. D'Agostino, L., Pignata, S., Daniele, B., D'Adamo, G., Ferraro, C., Silvestro, G., Tagliaferri, P., Contegiacomo, A., Gentile, R., Tritto, G., Bianco, A. R., and Mazzacca, G. Polyamine uptake by human colon carcinoma cell line CaCo-2. Digestion, 46: 352-359, 1990.
10. Minchin, R. F., Raso, A., Martin, R. L., and Ilett, K. F. Evidence for the existence of distinct transporters for the polyamines putrescine and spermidine in B16 melanoma cells. Eur. J. Biochem., 200: 457-462, 1991.
11. Lessard, M., Zhao, C., Singh, S. M., and Poulin, R. Hormonal and feedback regulation of putrescine and spermidine transport in human breast cancer cells. J. Biol. Chem., 270: 1685-1694, 1995.
12. Walters, J. D., and Wojcik, M, S. Polyamine transport in human promyelocytic leukemia cells and polymorphonuclear leukocytes. Leuk. Res., 18: 703-708, 1994.
13. Fontana, L., Colombatto, S., and Grillo, M. A. Regulation of spermidine transport in L1210 cells. Int. J. Biochem., 25: 1497-1500, 1993.
14. Byers, T. L., Kameji, R., Runnels, D. E., and Pegg, A. E. Multiple pathways for uptake of paraquat, methylglyoxal bis(guanylhydrazone), and polyamines. Am. J. Physiol., 252: C663-C669, 1987.
15. 4-spermidine derivatives and their potential in anticancer chemotherapy. Cancer Res., 42: 4072-4078, 1982.
16. Porter, C. W., Miller, J., and Bergeron, R. J. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells. Cancer Res., 44: 126-128, 1984.
17. 8-spermidine derivatives in cultured L1210 leukemia cells. Cancer Res., 45: 2050-2057, 1985.
18. Bergeron, R. J., Hawthorne, T. R., Vinson, J. R. T., Beck, D. E., Jr., and Ingeno, M. J. Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. Cancer Res., 49: 2959-2964, 1989.
19. Bergeron, R. J., McManis, J. S., Weimar, W. R., Schreier, K. M., Gao, F., Wu, Q., Ortiz-Ocasio, J., Luchetta, G. R., Porter, C., and Vinson, J. R. T. The role of charge in polyamine analogue recognition. J. Med. Chem., 38: 2278-2285, 1995.
20. Bergeron, R. J., McManis, J. S., Liu, C. Z., Feng, Y., Weimar, W. R., Luchetta, G. R., Wu, Q., Ortiz-Ocasio, J., Vinson, J. R. T., Kramer, D., and Porter, C. Antiproliferative properties of polyamine analogs: a structure-activity study. J. Med. Chem., 37: 3464-3476, 1994.
21. Holley, J., Mather, A., Cullis, P., Symons, M. R., Wardman, P., Watt, R. A., and Cohen, G. M. Uptake and cytotoxicity of novel nitroimidazole-polyamine conjugates in Ehrlich ascites tumour cells. Biochem. Pharmacol., 43: 763-769, 1992.
22. Stark, P. A., Thrall, B. D., Meadows, G. G., and Abdel-Monem, M. M. Synthesis and evaluation of novel spermidine derivatives as targeted cancer chemotherapeutic agents. J. Med. Chem., 35: 4264-4269, 1992.
23. Holley, J. L., Mather, J., Wheelhouse, R. T., Cullis, P. M., Hartley, J. A., Bingham, J. P., and Cohen, G. M. Targeting of tumor cells and DNA by a chlorambucil-spermidine conjugate. Cancer Res., 52: 4190-4195, 1992.
24. Heston, W. D. W., Yang, C-R., Pliner, L., Russo, P., and Covey, D. F. Cytotoxic activity of a polyamine analogue, monoaziridinylputrescine, against the PC-3 human prostatic carcinoma cell line. Cancer Res., 47: 3627-3631, 1987.
25. 8-aziridinyl analogues of spermidine. Biochem. Pharmacol., 47: 1587-1592, 1994.
26. Li, Y., Eiseman, J. L., Sentz, D. L., Rogers, F. A., Pan, S-S., Hu, L-T., Egorin, M. J., and Gallery, P. S. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane. J. Med. Chem., 39: 339-341, 1996.
27. Khan, N. A., Masson, I., Darcel, F., Quemener, F., Labarre, J-F., and Moulinoux, J-Ph. Transport mechanism of DIAM 3, a new anticancer drug, in human glioblastoma (U251) cells in culture. Biochem. Pharmacol., 39: 2057-2060, 1990.
28. Cramer, R. D., III, Patterson, D. E., and Bunce, J. D. Comparative molecular field analysis (CoMFA). I. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 110: 5959-5967, 1988.
29. Cramer, C. J., Famini, G. R., and Lowrey, A. H. Use of calculated quantum chemical properties as surrogates for solvatochromic parameters in structure-activity relationships. Ace. Chem. Res., 26: 599-605, 1993.
30. Harpalani, A. D., Snyder, S. W., Subramanyam, B., Egorin, M. J., and Callery, P. S. Alkylamides as inducers of human leukemia cell differentiation: a quantitative structure-activity relationship study using comparative molecular field analysis. Cancer Res., 53: 766-771, 1993.
31. Raghavan, K., Buolamwini, J. K., Fesen, M. R., Pommier, Y., Kohn, K. W., and Weinstein, J. N. Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study. J. Med. Chem., 38: 890-897, 1995.
32. Wu, Y-Y. Synthesis and evaluation of aziridine-containing compounds as inhibitors of porcine kidney diamine oxidase (Thesis). Baltimore, MD: University of Maryland, 1994.
33. Labadi, I., Jenei, E., Lahti, R., and Lonnberg, H. Interactions of pyrophosphate ion with di-, tri- and tetra-amines in aqueous solution: a potentiometric and calorimetric study. Acta Chem. Scand., 45: 1055-1059, 1991.
34. Delaby, R., Damiens, R., and D'Huyteza, G. lodures d'oxazolidyl-polymethylene-trialcoylammonium. Etude chimique et pharmacodynamique (in French). Ann. Pharm. Fr., 13: 565-576, 1955.
35. Chello, P. L., Sirotnak, F. M., Dorick, D. M., Yang, C-H., and Montgomery, J. A. Initial rate kinetics and evidence of duality in mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells. Cancer Res., 43: 97-103, 1983.
36. Dewar, M, J., Zoebisch, E. G., Healy, E. F., and Stewart, J. J. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc., 107: 3902-3909, 1985.
37. Cramer, C. J., and Truhlar, D. G. General parameterized SCF model for free energies of solvation in aqueous solution. J. Am. Chem. Soc., 113: 8305-8311, 1991.
38. Cramer, C. J., and Truhlar, D. G. An SCF solvation model for the hydrophobic effect and absolute free energies of aqueous solvation. Science (Washington DC), 256: 213-217, 1992.
39. Iitaka, Y., and Huse, Y. The crystal structure of spermine phosphate hexahydrate. Acta Cryst., 18: 110-121, 1965.
40. Bratek-Wiewiorowska, M. D., Alejska, M., Perkowska, A., Wiewiorowski, M., Jaskolski, M., and Cramer, F. Comparative structural analysis of the salts of putrescine (Pu), spermidine (Spd), and spermine (Sp) in the aspect of their interactions with nucleic acids. III. Hydrogen bonding systems in single crystals of hydrochlorides and hydrated phosphates of Pu, Spd, and Sp. Bull. Pol. Acad. Sci. Chem., 34: 229-249, 1986.
41. Giglio, E., Liquiori, A. M., Putiti, R., and Ripamonti, A. The crystal structure of spermine tetrahydrochloride. Acta Cryst., 20: 652-659, 1966.
42. a contributions to the binding and activity of cocaine, WIN32065-2, and WIN vinyl analog. J. Am. Chem. Soc., 116: 8722-8732, 1994.
43. 1 and implications for catalysis. J. Mol. Biol., 247: 774-807, 1995.